This trial is testing the best dose of radiation to give with an antibody that targets cancer cells, in order to prepare patients for a stem cell transplant.
2 Primary · 5 Secondary · Reporting Duration: Up to 5 years post-transplant
Experimental Treatment
40 Total Participants · 1 Treatment Group
Primary Treatment: Hematopoietic Cell Transplantation · No Placebo Group · Phase 1 & 2
Age 18 - 49 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: